Eosinophils and mast cells in leishmaniasis

Immunologic Research

Volumn 59, Issue 1-3, 2014, Pages 129-141

  Rodríguez, Nilda E ^a   Wilson, Mary E ^b,c  

^a UNIVERSITY OF NORTHERN IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Eosinophils; Innate immunity; Leishmania; Mast cells

Indexed keywords

GAMMA INTERFERON; HISTAMINE; INTERLEUKIN 12; IFNG PROTEIN, HUMAN;

ADAPTIVE IMMUNITY; AMASTIGOTE; EOSINOPHIL; HOST PARASITE INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; INTERFERON PRODUCTION; LEISHMANIA; LEISHMANIASIS; MACROPHAGE; MAST CELL; NEUTROPHIL; NONHUMAN; OUTCOME ASSESSMENT; PHAGOCYTOSIS; PRIORITY JOURNAL; PSYCHODIDAE; REVIEW; ANIMAL; ART; IMMUNOLOGY; PATHOLOGY;

ANIMALS; EOSINOPHILS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-12; LEISHMANIA; LEISHMANIASIS; MAST CELLS; PHAGOCYTOSIS; PORTRAITS AS TOPIC;

EID: 84905757166     PISSN: 0257277X     EISSN: 15590755     Source Type: Journal    
DOI: 10.1007/s12026-014-8536-x     Document Type: Review

References (120)

1. de Almeida MC, Vilhena V, Barral A, Barral-Netto M. Leishmanial infection: analysis of its first steps - a review. Mem Inst Oswaldo Cruz. 2003;98(7):861-70. (Pubitemid 38019533)
2. Rivas L, Moreno J, Canavate C, Alvar J. Virulence and disease in leishmaniasis: What is relevant for the patient? Trends Parasitol. 2004;20(7):297-301. (Pubitemid 38749069)
3. Pearson RD, Sousa AQ. Clinical spectrum of leishmaniasis. Clin Infect Dis. 1996;22(1):1-13. (Pubitemid 26022004)
4. Magill AJ, Grogl M, Gasser RA Jr, Sun W, Oster CN. Visceral infection caused by Leishmania tropica in veterans of operation desert storm. N Engl J Med. 1993;328(19):1383-7. (Pubitemid 23131391)
5. Aleixo JA, Nascimento ET, Monteiro GR, Fernandes MZ, Ramos AM, Wilson ME, et al. Atypical American visceral leishmaniasis caused by disseminated Leishmania amazonensis infection presenting with hepatitis and adenopathy. Trans R Soc Trop Med Hyg. 2006;100(1):79-82. (Pubitemid 41700196)
6. Mebrahtu YB, Van Eys G, Guizani I, Lawyer PG, Pamba H, Koech D, et al. Human cutaneous leishmaniasis caused by Leishmania donovani s.l. in Kenya. Trans R Soc Trop Med Hyg. 1993;87(5):598-601.
7. Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis. 2004;27(5):305-18. (Pubitemid 38842803)
8. Faulde M, Schrader J, Heyl G, Amirih M, Hoerauf A. Zoonotic cutaneous leishmaniasis outbreak in Mazar-e Sharif, northern Afghanistan: an epidemiological evaluation. Int J Med Microbiol. 2008;298(5-6):543-50. doi:10.1016/j.ijmm.2007.07.015. (Pubitemid 351756492)
9. Bates PA. The developmental biology of Leishmania promastigotes. Exp Parasitol. 1994;79(2):215-8. (Pubitemid 24277236)
10. Gossage SM, Rogers ME, Bates PA. Two separate growth phases during the development of Leishmania in sand flies: implications for understanding the life cycle. Int J Parasitol. 2003;33(10):1027-34. (Pubitemid 37297530)
11. Bates PA, Rogers ME. New insights into the developmental biology and transmission mechanisms of Leishmania. Curr Mol Med. 2004;4(6):601-9. (Pubitemid 39172366)
12. Sacks DL, Pimenta PF, McConville MJ, Schneider P, Turco SJ. Stage-specific binding of Leishmania donovani to the sand fly vector midgut is regulated by conformational changes in the abundant surface lipophosphoglycan. J Exp Med. 1995;181(2):685-97.
13. Castilho TM, Goldsmith-Pestana K, Lozano C, Valderrama L, Saravia NG, McMahon-Pratt D. Murine model of chronic L. (Viannia) panamensis infection: role of IL-13 in disease. Eur J Immunol. 2010;40(10):2816-29. doi:10.1002/eji. 201040384.
14. Wilson ME, Young BM, Davidson BL, Mente KA, McGowan SE. The importance of TGF-beta in murine visceral leishmaniasis. J Immunol. 1998;161(11):6148-55. (Pubitemid 28535987)
15. Scott P, Natovitz P, Coffman RL, Pearce E, Sher A. Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J Exp Med. 1988;168(5):1675-84. (Pubitemid 19023255)
16. Blackwell J, Freeman J, Bradley D. Influence of H-2 complex on acquired resistance to Leishmania donovani infection in mice. Nature. 1980;283(5742):72-4. (Pubitemid 10170881)
17. McElrath MJ, Murray HW, Cohn ZA. The dynamics of granuloma formation in experimental visceral leishmaniasis. J Exp Med. 1988;167(6):1927-37.
18. Wilson ME, Sandor M, Blum AM, Young BM, Metwali A, Elliott D, et al. Local suppression of IFN-gamma in hepatic granulomas correlates with tissue-specific replication of Leishmania chagasi. J Immunol. 1996;156(6):2231-9.
19. Scott P. Development and regulation of cell-mediated immunity in experimental leishmaniasis. Immunol Res. 2003;27(2-3):489-98.
20. Jones DE, Elloso MM, Scott P. Host susceptibility factors to cutaneous leishmaniasis. Front Biosci. 1998;3:D1171-80.
21. Kaye P, Scott P. Leishmaniasis: complexity at the host-pathogen interface. Nat Rev Microbiol. 2011;9(8):604-15. doi:10.1038/nrmicro2608.
22. Awasthi A, Mathur RK, Saha B. Immune response to Leishmania infection. Indian J Med Res. 2004;119(6):238-58. (Pubitemid 39076953)
23. Schriefer A, Wilson ME, Carvalho EM. Recent developments leading toward a paradigm switch in the diagnostic and therapeutic approach to human leishmaniasis. Curr Opin Infect Dis. 2008;21(5):483-8. doi:10.1097/QCO. 0b013e32830d0ee8.
24. Bates PA. Transmission of Leishmania metacyclic promastigotes by phlebotomine sand flies. Int J Parasitol. 2007;37(10):1097-106. (Pubitemid 47042030)
25. Morris RV, Shoemaker CB, David JR, Lanzaro GC, Titus RG. Sandfly maxadilan exacerbates infection with Leishmania major and vaccinating against it protects against L. major infection. J Immunol. 2001;167(9):5226-30. (Pubitemid 33009759)
26. Lerner EA, Iuga AO, Reddy VB. Maxadilan, a PAC1 receptor agonist from sand flies. Peptides. 2007;28(9):1651-4. (Pubitemid 47361433)
27. Soares MB, Titus RG, Shoemaker CB, David JR, Bozza M. The vasoactive peptide maxadilan from sand fly saliva inhibits TNF-alpha and induces IL-6 by mouse macrophages through interaction with the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor. J Immunol. 1998;160(4):1811-6. (Pubitemid 28106468)
28. Brodie TM, Smith MC, Morris RV, Titus RG. Immunomodulatory effects of the Lutzomyia longipalpis salivary gland protein maxadilan on mouse macrophages. Infect Immun. 2007;75(5):2359-65. (Pubitemid 46744325)
29. Andrade BB, de Oliveira CI, Brodskyn CI, Barral A, Barral-Netto M. Role of sand fly saliva in human and experimental leishmaniasis: current insights. Scand J Immunol. 2007;66(2-3):122-7. doi:10.1111/j.1365-3083.2007.01964.x. (Pubitemid 47063195)
30. de Oliveira CI, Nascimento IP, Barral A, Soto M, Barral-Netto M. Challenges and perspectives in vaccination against leishmaniasis. Parasitol Int. 2009;58(4):319-24. doi:10.1016/j.parint.2009.07.013.
31. Ilgoutz SC, McConville MJ. Function and assembly of the Leishmania surface coat. Int J Parasitol. 2001;31(9):899-908. doi:10.1016/s0020-7519(01) 00197-7. (Pubitemid 32530624)
32. Galvao-Quintao L, Alfieri SC, Ryter A, Rabinovitch M. Intracellular differentiation of Leishmania amazonensis promastigotes to amastigotes: presence of megasomes, cysteine proteinase activity and susceptibility to leucine-methyl ester. Parasitology. 1990;101(Pt 1):7-13. (Pubitemid 20297284)
33. McConville MJ, de Souza D, Saunders E, Likic VA, Naderer T. Living in a phagolysosome; metabolism of Leishmania amastigotes. Trends Parasitol. 2007;23(8):368-75. doi:10.1016/j.pt.2007.06.009. (Pubitemid 47069957)
34. Piani A, Ilg T, Elefanty AG, Curtis J, Handman E. Leishmania major proteophosphoglycan is expressed by amastigotes and has an immunomodulatory effect on macrophage function. Microbes Infect. 1999;1(8):589-99.
35. Wilson ME, Innes DJ, Sousa AD, Pearson RD. Early histopathology of experimental infection with Leishmania donovani in hamsters. J Parasitol. 1987;73(1):55-63. (Pubitemid 17119866)
36. Turetz ML, Machado PR, Ko AI, Alves F, Bittencourt A, Almeida RP, et al. Disseminated leishmaniasis: a new and emerging form of leishmaniasis observed in northeastern Brazil. J Infect Dis. 2002;186(12):1829-34. (Pubitemid 35463517)
37. Belkaid Y, Mendez S, Lira R, Kadambi N, Milon G, Sacks D. A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity. J Immunol. 2000;165(2):969-77. (Pubitemid 30484766)
38. Preston PM, Dumonde DC. Experimental cutaneous leishmaniasis. V. Protective immunity in subclinical and self-healing infection in the mouse. Clin Exp Immunol. 1976;23(1):126-38.
39. Bretscher PA, Wei G, Menon JN, Bielefeldt-Ohmann H. Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science. 1992;257(5069):539-42.
40. Barral A, Barral-Netto M, Yong EC, Brownell CE, Twardzik DR, Reed SG. Transforming growth factor beta as a virulence mechanism for Leishmania braziliensis. Proc Natl Acad Sci USA. 1993;90(8):3442-6. (Pubitemid 23111382)
41. Wilson ME, Recker TJ, Rodriguez NE, Young BM, Burnell KK, Streit JA, et al. The TGF-beta response to Leishmania chagasi in the absence of IL-12. Eur J Immunol. 2002;32(12):3556-65. (Pubitemid 36024392)
42. Peters NC, Egen JG, Secundino N, Debrabant A, Kimblin N, Kamhawi S, et al. In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies. Science. 2008;321(5891):970-4.
43. Thalhofer CJ, Chen Y, Sudan B, Love-Homan L, Wilson ME. Leukocytes infiltrate the skin and draining lymph nodes in response to the protozoan Leishmania infantum chagasi. Infect Immun. 2011;79(1):108-17. doi:10.1128/iai.00338-10.
44. Padigel UM, Lee JJ, Nolan TJ, Schad GA, Abraham D. Eosinophils can function as antigen-presenting cells to induce primary and secondary immune responses to Strongyloides stercoralis. Infect Immun. 2006;74(6):3232-8. (Pubitemid 43794511)
45. Blanchard C, Rothenberg ME. Biology of the eosinophil. Adv Immunol. 2009;101:81-121. doi:10.1016/s0065-2776(08)01003-1.
46. Akuthota P, Wang H, Weller PF. Eosinophils as antigen-presenting cells in allergic upper airway disease. Curr Opin Allergy Clin Immunol. 2010;10(1):14-9. doi:10.1097/ACI.0b013e328334f693.
47. Jacobsen EA, Taranova AG, Lee NA, Lee JJ. Eosinophils: singularly destructive effector cells or purveyors of immunoregulation? J Allergy Clin Immunol. 2007;119(6):1313-20. (Pubitemid 46855871)
48. Odemuyiwa SO, Ghahary A, Li Y, Puttagunta L, Lee JE, Musat-Marcu S, et al. Cutting edge: human eosinophils regulate T cell subset selection through indoleamine 2,3-dioxygenase. J Immunol. 2004;173(10):5909-13. (Pubitemid 39487742)
49. Garro AP, Chiapello LS, Baronetti JL, Masih DT. Eosinophils elicit proliferation of naive and fungal-specific cells in vivo so enhancing a T helper type 1 cytokine profile in favour of a protective immune response against Cryptococcus neoformans infection. Immunology. 2011;134(2):198-213. doi:10.1111/j.365-2567.011.03479.x.
50. de Oliveira Cardoso F, de Souza Cda S, Mendes VG, Abreu-Silva AL, Goncalves da Costa SC, Calabrese KS. Immunopathological studies of Leishmania amazonensis infection in resistant and in susceptible mice. J Infect Dis. 2010;201(12):1933-40.
51. Saito S, Hamada A, Watanabe N, Obata T, Katakura K, Ohtomo H. Eosinophil chemotactic activity in Leishmania amazonensis promastigotes. Parasitol Res. 1996;82(6):485-9. (Pubitemid 26228485)
52. Grimaldi G Jr, Soares MJ, Moriearty PL. Tissue eosinophilia and Leishmania mexicana mexicana eosinophil interactions in murine cutaneous leishmaniasis. Parasite Immunol. 1984;6(5):397-408. (Pubitemid 14005559)
53. Pearson RD, Uydess IL, Chapman SW, Steigbigel RT. Interaction of human eosinophils with Leishmania donovani. Ann Trop Med Parasitol. 1987;81(6):735-9. (Pubitemid 18073238)
54. Pimenta PF, Dos Santos MA, De Souza W. Fine structure and cytochemistry of the interaction between Leishmania mexicana amazonensis and rat neutrophils and eosinophils. J Submicrosc Cytol. 1987;19(3):387-95.
55. Menezes-Souza D, Guerra-Sa R, Carneiro CM, Vitoriano-Souza J, Giunchetti RC, Teixeira-Carvalho A, et al. Higher expression of CCL2, CCL4, CCL5, CCL21, and CXCL8 chemokines in the skin associated with parasite density in canine visceral leishmaniasis. PLoS Negl Trop Dis. 2012;6(4):e1566. doi:10.371/journal.pntd.0001566.
56. Bomfim G, Andrade BB, Santos S, Clarencio J, Barral-Netto M, Barral A. Cellular analysis of cutaneous leishmaniasis lymphadenopathy: insights into the early phases of human disease. Am J Trop Med Hyg. 2007;77(5):854-9. (Pubitemid 351837830)
57. Guerra CS, Silva RM, Carvalho LO, Calabrese kDa S, Bozza PT, Corte-Real S. Histopathological analysis of initial cellular response in TLR-2 deficient mice experimentally infected by Leishmania (L.) amazonensis. Int J Exp Pathol. 2010;91(5):451-9. doi:10.1111/j.1365-2613.2010.00717.x.
58. Oliveira SH, Fonseca SG, Romao PR, Ferreira SH, Cunha FQ. Nitric oxide mediates the microbicidal activity of eosinophils. Mem Inst Oswaldo Cruz. 1997;92(Suppl 2):233-5.
59. Watanabe Y, Hamaguchi-Tsuru E, Morimoto N, Nishio Y, Yagyu K, Konishi Y, et al. IL-5-Induced eosinophils suppress the growth of Leishmania amazonensis in vivo and kill promastigotes in vitro in response to either IL-4 or IFN-gamma. DNA Cell Biol. 2004;23(7):412-8. (Pubitemid 38981975)
60. Fonseca SG, Romao PR, Figueiredo F, Morais RH, Lima HC, Ferreira SH, et al. TNF-alpha mediates the induction of nitric oxide synthase in macrophages but not in neutrophils in experimental cutaneous leishmaniasis. Eur J Immunol. 2003;33(8):2297-306. (Pubitemid 37025096)
61. Gantt KR, Goldman TL, McCormick ML, Miller MA, Jeronimo SM, Nascimento ET, et al. Oxidative responses of human and murine macrophages during phagocytosis of Leishmania chagasi. J Immunol. 2001;167(2):893-901. (Pubitemid 32660845)
62. Nandan D, Lo R, Reiner NE. Activation of phosphotyrosine phosphatase activity attenuates mitogen-activated protein kinase signaling and inhibits c-FOS and nitric oxide synthase expression in macrophages infected with Leishmania donovani. Infect Immun. 1999;67(8):4055-63. (Pubitemid 29357028)
63. Liew FY, Li Y, Moss D, Parkinson C, Rogers MV, Moncada S. Resistance to Leishmania major infection correlates with the induction of nitric oxide synthase in murine macrophages. Eur J Immunol. 1991;21(12):3009-14.
64. Monteiro MC, Lima HC, Souza AA, Titus RG, Romao PR, Cunha FQ. Effect of Lutzomyia longipalpis salivary gland extracts on leukocyte migration induced by Leishmania major. Am J Trop Med Hyg. 2007;76(1):88-94. (Pubitemid 351627808)
65. Peruhype-Magalhaes V, Martins-Filho OA, Prata A, Silva Lde A, Rabello A, Teixeira-Carvalho A, et al. Immune response in human visceral leishmaniasis: analysis of the correlation between innate immunity cytokine profile and disease outcome. Scand J Immunol. 2005;62(5):487-95. (Pubitemid 41719325)
66. Stirling RG, van Rensen EL, Barnes PJ, Chung KF. Interleukin-5 induces CD34(+) eosinophil progenitor mobilization and eosinophil CCR3 expression in asthma. Am J Respir Crit Care Med. 2001;164(8 Pt 1):1403-9. (Pubitemid 33130038)
67. Tominaga A, Takaki S, Koyama N, Katoh S, Matsumoto R, Migita M, et al. Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production. J Exp Med. 1991;173(2):429-37.
68. Nakajima H, Gleich GJ, Kita H. Constitutive production of IL-4 and IL-10 and stimulated production of IL-8 by normal peripheral blood eosinophils. J Immunol. 1996;156(12):4859-66.
69. Jeronimo SM, Duggal P, Braz RF, Cheng C, Monteiro GR, Nascimento ET, et al. An emerging peri-urban pattern of infection with Leishmania chagasi, the protozoan causing visceral leishmaniasis in northeast Brazil. Scand J Infect Dis. 2004;36(6-7):443-9. (Pubitemid 39089194)
70. Eady RA, Cowen T, Marshall TF, Plummer V, Greaves MW. Mast cell population density, blood vessel density and histamine content in normal human skin. Br J Dermatol. 1979;100(6):623-33. (Pubitemid 9250115)
71. Bischoff SC. Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data. Nat Rev Immunol. 2007;7(2):93-104. (Pubitemid 46174857)
72. Bidri M, Feger F, Varadaradjalou S, Ben Hamouda N, Guillosson JJ, Arock M. Mast cells as a source and target for nitric oxide. Int Immunopharmacol. 2001;1(8):1543-58. (Pubitemid 32622797)
73. Galli SJ, Nakae S, Tsai M. Mast cells in the development of adaptive immune responses. Nat Immunol. 2005;6(2):135-42. (Pubitemid 40268194)
74. Stelekati E, Orinska Z, Bulfone-Paus S. Mast cells in allergy: innate instructors of adaptive responses. Immunobiology. 2007;212(6):505-19. (Pubitemid 46825249)
75. Bidri M, Vouldoukis I, Mossalayi MD, Debre P, Guillosson JJ, Mazier D, et al. Evidence for direct interaction between mast cells and Leishmania parasites. Parasite Immunol. 1997;19(10):475-83. (Pubitemid 27472928)
76. Feger F, Varadaradjalou S, Gao Z, Abraham SN, Arock M. The role of mast cells in host defense and their subversion by bacterial pathogens. Trends Immunol. 2002;23(3):151-8. (Pubitemid 34178298)
77. Shin JS, Gao Z, Abraham SN. Involvement of cellular caveolae in bacterial entry into mast cells. Science. 2000;289(5480):785-8. (Pubitemid 30650200)
78. de Oliveira MP, Lima MC, Calheiros AS, Martins MA, Antas PR, De Luca PM, et al. Leishmania (Viannia) braziliensis: human mast cell line activation induced by logarithmic and stationary promastigote derived-lysates. Exp Parasitol. 2005;109(2):72-9. (Pubitemid 40431331)
79. von Stebut E, Metz M, Milon G, Knop J, Maurer M. Early macrophage influx to sites of cutaneous granuloma formation is dependent on MIP-1alpha/beta released from neutrophils recruited by mast cell-derived TNFalpha. Blood. 2003;101(1):210-5. (Pubitemid 36025910)
80. Kanbe N, Kurosawa M, Nagata H, Saitoh H, Miyachi Y. Cord blood-derived human cultured mast cells produce transforming growth factor beta1. Clin Exp Allergy. 1999;29(1):105-13. (Pubitemid 29067659)
81. Smith TJ, Ducharme LA, Weis JH. Preferential expression of interleukin-12 or interleukin-4 by murine bone marrow mast cells derived in mast cell growth factor or interleukin-3. Eur J Immunol. 1994;24(4):822-6. (Pubitemid 24093776)
82. Sacks D, Noben-Trauth N. The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol. 2002;2(11):845-58. (Pubitemid 37328707)
83. Wershil BK, Theodos CM, Galli SJ, Titus RG. Mast cells augment lesion size and persistence during experimental Leishmania major infection in the mouse. J Immunol. 1994;152(9):4563-71. (Pubitemid 24134415)
84. Romao PR, Da Costa Santiago H, Ramos CD, De Oliveira CF, Monteiro MC, De Queiroz Cunha F, et al. Mast cell degranulation contributes to susceptibility to Leishmania major. Parasite Immunol. 2009;31(3):140-6.
85. Palomaki VA, Laitinen JT. The basic secretagogue compound 48/80 activates G proteins indirectly via stimulation of phospholipase D-lysophosphatidic acid receptor axis and 5-HT1A receptors in rat brain sections. Br J Pharmacol. 2006;147(6):596-606.
86. Murray HW, Squires KE, Miralles CD, Stoeckle MY, Granger AM, Granelli-Piperno A, et al. Acquired resistance and granuloma formation in experimental visceral leishmaniasis. Differential T cell and lymphokine roles in initial versus established immunity. J Immunol. 1992;148(6):1858-63.
87. Kindler V, Sappino AP, Grau GE, Piguet PF, Vassalli P. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell. 1989;56(5):731-40. (Pubitemid 19082507)
88. Mielke ME, Rosen H, Brocke S, Peters C, Hahn H. Protective immunity and granuloma formation are mediated by two distinct tumor necrosis factor alpha- and gamma interferon-dependent T cell-phagocyte interactions in murine listeriosis: dissociation on the basis of phagocyte adhesion mechanisms. Infect Immun. 1992;60(5):1875-82.
89. Amiri P, Locksley RM, Parslow TG, Sadick M, Rector E, Ritter D, et al. Tumour necrosis factor alpha restores granulomas and induces parasite egg-laying in schistosome-infected SCID mice. Nature. 1992;356(6370):604-7.
90. Maurer M, Lopez Kostka S, Siebenhaar F, Moelle K, Metz M, Knop J, et al. Skin mast cells control T cell-dependent host defense in Leishmania major infections. Faseb J. 2006;20(14):2460-7. (Pubitemid 44953818)
91. Romagnani S. T-cell subsets (Th1 versus Th2). Ann Allergy Asthma Immunol. 2000;85(1):9-18 quiz, 21.
92. Saha B, Tonkal AM, Croft S, Roy S. Mast cells at the hostpathogen interface: host-protection versus immune evasion in leishmaniasis. Clin Exp Immunol. 2004;137(1):19-23. (Pubitemid 38869773)
93. Saha B, Saini A, Germond R, Perrin PJ, Harlan DM, Davis TA. Susceptibility or resistance to Leishmania infection is dictated by the macrophages evolved under the influence of IL-3 or GM-CSF. Eur J Immunol. 1999;29(7):2319-29. (Pubitemid 29313107)
94. Feng ZY, Louis J, Kindler V, Pedrazzini T, Eliason JF, Behin R, et al. Aggravation of experimental cutaneous leishmaniasis in mice by administration of interleukin 3. Eur J Immunol. 1988;18(8):1245-51.
95. Villasenor-Cardoso MI, Salaiza N, Delgado J, Gutierrez-Kobeh L, Perez-Torres A, Becker I. Mast cells are activated by Leishmania mexicana LPG and regulate the disease outcome depending on the genetic background of the host. Parasite Immunol. 2008;30(8):425-34.
96. Tuon FF, Duarte MI, Amato VS. A quantitative and morphometric study of mast cells in cutaneous leishmaniasis. Parasite Immunol. 2008;30(11-12):641-5.
97. Turygin VV, Babik TM, Boyakov AA. Characteristics of mast cells in the choroid plexus of the ventricles of the human brain in aging. Neurosci Behav Physiol. 2005;35(9):909-11. (Pubitemid 41683381)
98. Hart PH, Grimbaldeston MA, Hosszu EK, Swift GJ, Noonan FP, Finlay-Jones JJ. Age-related changes in dermal mast cell prevalence in BALB/c mice: functional importance and correlation with dermal mast cell expression of kit. Immunology. 1999;98(3):352-6. (Pubitemid 29526956)
99. Schneider E, Pollard H, Lepault F, Guy-Grand D, Minkowski M, Dy M. Histamine-producing cell-stimulating activity. Interleukin 3 and granulocyte-macrophage colony-stimulating factor induce de novo synthesis of histidine decarboxylase in hemopoietic progenitor cells. J Immunol. 1987;139(11):3710-7. (Pubitemid 18013646)
100. Schneider E, Rolli-Derkinderen M, Arock M, Dy M. Trends in histamine research: new functions during immune responses and hematopoiesis. Trends Immunol. 2002;23(5):255-63. (Pubitemid 34499563)
101. Jutel M, Watanabe T, Klunker S, Akdis M, Thomet OA, Malolepszy J, et al. Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature. 2001;413(6854):420-5. (Pubitemid 32928596)
102. Pos Z, Muller K, Novalphak I, Buzas E, Solbach W, Falus A, et al. Different patterns of the L-histidine decarboxylase (HDC) gene expression in mice resistant and susceptible to experimental cutaneous leishmaniasis. Inflamm Res. 2004;53(1):38-43. (Pubitemid 38121834)
103. O'Mahony L, Akdis M, Akdis CA. Regulation of the immune response and inflammation by histamine and histamine receptors. J Allergy Clin Immunol. 2011;128(6):1153-62. doi:10.1016/j.jaci.2011.06.051.
104. Jutel M, Blaser K, Akdis CA. The role of histamine in regulation of immune responses. Chem Immunol Allergy. 2006;91:174-87. doi:10.1159/000090280. (Pubitemid 43097205)
105. Caron G, Delneste Y, Roelandts E, Duez C, Bonnefoy JY, Pestel J, et al. Histamine polarizes human dendritic cells into Th2 cell-promoting effector dendritic cells. J Immunol. 2001;167(7):3682-6. (Pubitemid 32910811)
106. Grimbaldeston MA, Nakae S, Kalesnikoff J, Tsai M, Galli SJ. Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat Immunol. 2007;8(10):1095-104. (Pubitemid 47423757)
107. van Zandbergen G, Klinger M, Mueller A, Dannenberg S, Gebert A, Solbach W, et al. Cutting edge: neutrophil granulocyte serves as a vector for Leishmania entry into macrophages. J Immunol. 2004;173(11):6521-5. (Pubitemid 39541033)
108. Himmelrich H, Parra-Lopez C, Tacchini-Cottier F, Louis JA, Launois P. The IL-4 rapidly produced in BALB/c mice after infection with Leishmania major down-regulates IL-12 receptor beta 2-chain expression on CD4 + T cells resulting in a state of unresponsiveness to IL-12. J Immunol. 1998;161(11):6156-63. (Pubitemid 28535988)
109. Scharton TM, Scott P. Natural killer cells are a source of interferon gamma that drives differentiation of CD4 + T cell subsets and induces early resistance to Leishmania major in mice. J Exp Med. 1993;178(2):567-77. (Pubitemid 23218205)
110. Biedermann T, Zimmermann S, Himmelrich H, Gumy A, Egeter O, Sakrauski AK, et al. IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice. Nat Immunol. 2001;2(11):1054-60. (Pubitemid 33069501)
111. Horvath BV, Szalai C, Mandi Y, Laszlo V, Radvany Z, Darvas Z, et al. Histamine and histamine-receptor antagonists modify gene expression and biosynthesis of interferon gamma in peripheral human blood mononuclear cells and in CD19-depleted cell subsets. Immunol Lett. 1999;70(2):95-9. (Pubitemid 29467448)
112. Kawakami T, Galli SJ. Regulation of mast-cell and basophil function and survival by IgE. Nat Rev Immunol. 2002;2(10):773-86. (Pubitemid 37328717)
113. Takahashi HK, Yoshida A, Iwagaki H, Yoshino T, Itoh H, Morichika T, et al. Histamine regulation of interleukin-18-initiating cytokine cascade is associated with down-regulation of intercellular adhesion molecule-1 expression in human peripheral blood mononuclear cells. J Pharmacol Exp Ther. 2002;300(1):227-35. (Pubitemid 34028532)
114. Localized Leishmania lymphadenitis. Immunohistochemical studies, (1994).
115. Elenkov IJ, Webster E, Papanicolaou DA, Fleisher TA, Chrousos GP, Wilder RL. Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors. J Immunol. 1998;161(5):2586-93. (Pubitemid 28397078)
116. Nair MG, Gallagher IJ, Taylor MD, Loke P, Coulson PS, Wilson RA, et al. Chitinase and Fizz family members are a generalized feature of nematode infection with selective upregulation of Ym1 and Fizz1 by antigen-presenting cells. Infect Immun. 2005;73(1):385-94. doi:10.1128/iai.73.1.385-394.2005. (Pubitemid 40041131)
117. Gordon S. Alternative activation of macrophages. Nat Rev Immunol. 2003;3(1):23-35. (Pubitemid 37328697)
118. Mosser DM. The many faces of macrophage activation. J Leukoc Biol. 2003;73(2):209-12. (Pubitemid 36158295)
119. Wilson ME, Jeronimo SM, Pearson RD. Immunopathogenesis of infection with the visceralizing Leishmania species. Microb Pathog. 2005;38(4):147-60. (Pubitemid 40417730)
120. Reiner SL, Locksley RM. The regulation of immunity to Leishmania major. Annu Rev Immunol. 1995;13:151-77.